----- Original Message -----
From: De Gruyter, Sabine v. Wittke
To: kiehl@rki-i.com
Sent: Thursday, May 27, 2010 6:01 PM
Subject: Hormone Molecular Biology and Clinical Investigation

Hormone Molecular Biology and Clinical Investigation:
Your Access to New Content

Dear Colleague,

Prof. Pasqualini and the editors are delighted to offer you free access to the new journal Hormone Molecular Biology and Clinical Investigation (HMBCI).

Comprehensive Scope
HMBCI is dedicated to the provision of basic data on molecular aspects of hormones in physiology and pathophysiology. The journal will cover the treatment of major diseases, dysfunctions and deficiencies, as well as new data on the different steps and factors involved in the mechanism of hormone action. It will equally examine the relation of hormones with the immune system and its environment, as well as new developments in hormone measurements.


To obtain your free access, simply do the following:

If you are a new user of Reference Global:
Register free of charge at www.reference-global.com. Here you will be able to type in your Access Token to activate your free access: HMBCI1M_MK. Please note that Access Tokens are case sensitive.
You will then find the articles of HMBCI for free in your Account under the Access tab, or just visit www.reference-global.com/loi/hmbci.

If you already have a user account:
Log in with you user name and password.
Once logged in, click here to activate your online access to HMBCI.
You will then find the articles of HMBCI for free in your Account under the Access tab, or just visit www.reference-global.com/loi/hmbci.

You will be able to activate your free access until July 31, 2010. It will be valid for 30 days after activation.

If you are interested in a printed free sample copy please send an e-mail to marketing@degruyter.com. (All requests are subject to publisher approval.)

For more information, please visit  www.degruyter.com/hmbci.

Register for our free TOC Alerts at www.reference-global.com and visit www.degruyter.com/newsletter to receive the latest news in your field of research.

We hope you find HBMCI a valuable resource.

Thank you for your kind cooperation and best regards,

Sabine v.Wittke-Holweg
Product Manager

PS.: Call for Papers: We are especially interested in encouraging highly qualified scientists to submit their work online at http://hmbci.edmgr.com, the online submission system of the journal. You are also welcome as a reviewer.

Walter de Gruyter GmbH & Co. KG

Genthiner Straße 13
10785 Berlin / Germany
Phone: +49 30 260 05-0
Fax: +49 30 260 05-251
Mail: info@deGruyter.com
Internet: www.degruyter.com

Domicile: Berlin. Amtsgericht Charlottenburg HR A 2065
Legal Form: Limited Partnership
General Partner: de Gruyter Verlagsbeteiligungs GmbH
Domicile: Berlin. Amtsgericht Charlottenburg, HR B 46487

Managing director: Dr. Sven Fund
Chairmen of the advisory board: Dr. Bernd Balzereit
Data protection: We treat all your personal data confidentially and guarantee that your e-mail address will not be disclosed to third parties. You are free to withdraw your consent to having your e-mail address saved and used for newsletters at any time. Your use of hyperlinks in e-mails and on websites is only evaluated anonymously. This rules out the building of personal user profiles. If you have any questions or suggestions about this service, please feel free to contact us at newsletter@degruyter.com.
If at any time you no longer want to receive information via e-mail from us, please let us know by replying to this e-mail.